Matrix Pharmacorp has announced the appointment of Sanjay Chaturvedi as its Chief Executive Officer, marking a significant leadership milestone for the company’s future growth and innovation roadmap.

Dr. Chaturvedi brings decades of rich experience across the pharmaceutical, biotechnology, and specialty chemicals sectors. His distinguished leadership journey includes key roles at Apitoria Pharma Private Limited, IOL Chemicals and Pharmaceuticals Limited, Praj Industries, Aurobindo Pharma, Dr. Reddy’s Laboratories, Dow Advanced Materials, and Rohm and Haas.

Recognized for his expertise in active pharmaceutical ingredients (API), research and development, global commercialization, operational excellence, and enterprise transformation, he has consistently driven business expansion and strategic growth across international markets.

His appointment is expected to further strengthen Matrix Pharmacorp’s position in the pharmaceutical industry while accelerating innovation, manufacturing excellence, and global market reach. 

CXO TechBOT wishes Sanjay Chaturvedi great success in his new role.